Business

December 30, 2013 3:39 PM

BioCryst receives another $2.5 million to develop Marburg virus drug

BioCryst Pharmaceuticals has received an additional $2.5 million in federal funding to further develop a treatment for Marburg virus disease.

Related content

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs